blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0713391

EP0713391 - METHOD OF INHIBITING THE PRODUCTION OF HUMAN IMMUNODEFICIENCY VIRUSES WITH SUBSTITUTED AZASPIRANES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.07.1999
Database last updated on 14.11.2024
Most recent event   Tooltip02.07.1999Application deemed to be withdrawnpublished on 18.08.1999 [1999/33]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
UW2220, 709 Swedeland Road, P.O. Box 1539
King of Prussia, PA 19406-0939 / US
[N/P]
Former [1996/22]For all designated states
SMITHKLINE BEECHAM CORPORATION
UW2220, 709 Swedeland Road, P.O. Box 1539
King of Prussia, PA 19406-0939 / US
Inventor(s)01 / BADGER, Alison, Mary
56 Parkridge Drive
Bryn Mawr, PA 19010 / US
[1996/22]
Representative(s)Wishart, Ian Carmichael
Patents Department Johnson Matthey Technology Centre Blount's Court Sonning Common
Reading, RG4 9NH / GB
[N/P]
Former [1999/03]Wishart, Ian Carmichael
Patents Department Johnson Matthey Technology Centre Blounts Court Sonning Common
Reading, Berks RG4 9NH / GB
Former [1997/14]Waters, David Martin, Dr.
Smithkline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Former [1996/22]Summersell, Richard John
SmithKline Beecham Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD / GB
Application number, filing date94922684.922.07.1994
[1996/22]
WO1994US08275
Priority number, dateGB1993001530623.07.1993         Original published format: GB 9315306
[1996/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9503041
Date:02.02.1995
Language:EN
[1995/06]
Type: A1 Application with search report 
No.:EP0713391
Date:29.05.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 02.02.1995 takes the place of the publication of the European patent application.
[1996/22]
Search report(s)International search report - published on:US02.02.1995
(Supplementary) European search report - dispatched on:EP22.07.1998
ClassificationIPC:A61K31/40, A61K31/44, A61K31/55, A61K31/435
[1998/34]
CPC:
A61K31/40 (EP); A61K31/435 (EP)
Former IPC [1996/22]A61K31/40, A61K31/44, A61K31/55
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/22]
Extension statesSI01.02.1996
TitleGerman:VERFAHREN ZUR HEMMUNG DER PRODUKTION VON HIV-VIREN MIT SUBSTITUIERTEN AZASPIRANEN[1996/22]
English:METHOD OF INHIBITING THE PRODUCTION OF HUMAN IMMUNODEFICIENCY VIRUSES WITH SUBSTITUTED AZASPIRANES[1996/22]
French:PROCEDE D'INHIBITION DE LA PRODUCTION DE VIRUS DE L'IMMUNODEFICIENCE CHEZ L'HOMME AU MOYEN D'AZASPIRANES SUBSTITUES[1996/22]
Entry into regional phase01.02.1996National basic fee paid 
01.02.1996Search fee paid 
01.02.1996Designation fee(s) paid 
01.02.1996Examination fee paid 
Examination procedure21.02.1995Request for preliminary examination filed
International Preliminary Examining Authority: US
01.02.1996Examination requested  [1996/22]
03.02.1999Application deemed to be withdrawn, date of legal effect  [1999/33]
16.03.1999Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1999/33]
Fees paidRenewal fee
08.07.1996Renewal fee patent year 03
10.06.1997Renewal fee patent year 04
29.06.1998Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO9503049  (SMITHKLINE BEECHAM CORP [US], et al) [E] 1-6 * the whole document *;
 [E]WO9503042  (SMITHKLINE BEECHAM CORP [US], et al) [E] 1-6 * the whole document *;
 [E]WO9503046  (SMITHKLINE BEECHAM CORP [US], et al) [E] 1,3-6 * the whole document *;
 [PX]WO9314760  (SMITHKLINE BEECHAM CORP [US]) [PX] 1-6 * the whole document *;
 [PX]WO9315735  (SMITHKLINE BEECHAM CORP [US]) [PX] 1,3-6 * the whole document *;
 [X]WO9214462  (SMITHKLINE BEECHAM CORP [US]) [X] 1-6 * abstract * * page 2, line 30 - page 7, line 11 * * page 8, line 19 - line 23 * * page 11, line 3 - line 12; claims 1-13,20,22-34,41 *;
 [Y]  - BADGER A M ET AL, "ANTIARTHRITIC AND SUPPRESSOR CELL INDUCING ACTIVITY OF AZASPIRANES:STRUCTURE-FUNCTION RELATIONSHIPS OF A NOVEL CLASS OF IMMUNOMODULATORY AGENTS", JOURNAL OF MEDICINAL CHEMISTRY, (199011), vol. 33, no. 11, pages 2963 - 2970, XP000605424 [Y] 1-6 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00173a010
 [Y]  - S. GOODMAN, "THERAPEUTIC EFFECTS OF ORGANIC GERMANIUM", MEDICAL HYPOTHESES, (1988), vol. 26, pages 207 - 215, XP002069578 [Y] 1-6 * abstract * * page 211, column L, paragraph 2 - column R, paragraph 1 * * page 212, column R, paragraph L - page 213, column L, paragraph L *

DOI:   http://dx.doi.org/10.1016/0306-9877(88)90101-6
 [Y]  - P.S. SARIN ET AL., "INHIBITION OF HTLV-III REPLICATION IN CELL CULTURES", NATO ASI SER., SER. A, (1986), vol. 120, pages 329 - 342, XP002069579 [Y] 1-6 * page 331, paragraph L - page 335, paragraph L; table 3 *
International search[X]US4963557  (BADGER ALISON M [US], et al);
 [X]WO9214462  ;
 [XP]WO9314760
 [X]  - CHEMICAL ABSTRACTS, Volume 117, No. 23, issued 07 December 1992, BADGER et al.: "Azaspirana Derivatives as Cytokine Inhibitors", see pages 83, column 2, abstract no. 226312z; & WO,A,9214462., & WO9214462 A 00000000
 [XP]  - CHEMICAL ABSTRACTS, Volume 119, No. 17, issued 25 October 1993, BADGER, "Preventing or Delaying Occurence of Acquired Immunodefiency Syndrome with Azaspiranes", see page 90, column 1, abstract no. 174173z; & WO,A,9314760., & WO9314760 A 00000000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.